4C Medical Technologies, Inc. is a medical device company developing a novel minimally invasive solution for the treatment of mitral regurgitation (MR). We are the first transcatheter MR therapy that directly addresses mitral regurgitation without replacing the native mitral valve, thus preserving the native mitral annulus and left ventricle. The device is positioned supra annular to the leaking native mitral valve to stop the leak from entering the left atrium. Its atrial only fixation ensures minimal disruption to critical cardiac structures within the left ventricle including the chordae tendineae and the left ventricular outflow tract. Our initial focus is to develop a novel therapy for mitral regurgitation (MR), and subsequently for tricuspid regurgitation (TR).
Location: United States, Minnesota, Maple Grove
Employees: 11-50
Total raised: $52.47M
Founded date: 2016
Investors 3
Funding Rounds 4
| Date | Series | Amount | Investors |
| 01.04.2022 | Series C | $35M | - |
| 17.03.2021 | - | $221K | Grant Park... |
| 30.09.2020 | - | $250K | Grant Park... |
| 11.09.2018 | Series A | $17M | - |
Mentions in press and media 28
| Date | Title | Description |
| 07.05.2024 | Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering | NEWTOWN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficit... |
| 06.05.2024 | Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering | - |
| 13.12.2022 | Monarch Medical Technologies Receives $5M Investment from Semler Scientific | Monarch Medical Technologies, a Charlotte, NC-based digital health company, received a $5M in investment from Semler Scientific (Nasdaq: SMLR). Semler Scientific, which provides technology solutions to improve the clinical effectiveness and... |
| 05.08.2022 | Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering | NEWTOWN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the pricing of a public offering of (i) 24,0... |
| 19.05.2022 | 4C Medical Technologies Presents Data from the Global Clinical Experience for the AltaValve Early Feasibility Study at AATS 2022 | MINNEAPOLIS, May 19, 2022 /PRNewswire/ -- 4C Medical Technologies, Inc. ("4C Medical" or the "Company"), a privately-held medical technology company focused on the development of minimally invasive therapies for structur... |
| 01.04.2022 | 4C Medical Technologies Closes $35M Series C Financing | 4C Medical Technologies, a Minneapolis, MN-based medical technology company, raised $35M in Series C funding. The round was led by MicroPort CardioFlow Medtech Corporation (HKEX:2160). The company intends to use the funds to develop its Alt... |
| 31.03.2022 | 4C Medical Technologies Nabs $35M, Appoints New President and CEO | What You Should Know: – 4C Medical Technologies, a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease raises $35.4M in Series C funding was led by MicroPort Card... |
| 19.02.2022 | Meihua International Medical Technologies Co., Ltd. Announces Closing of $39.4 Million Initial Public Offering | YANGZHOU, China, Feb. 19, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medica... |
| 16.02.2022 | Meihua International Medical Technologies Co., Ltd. Announces Pricing of $36,000,000 Initial Public Offering | YANGZHOU, China, Feb. 16, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medica... |
| 14.09.2021 | Vibrato Medical : Closes $4M Series A Funding Round and Receives $1.5M NIH Grant | Vibrato Medical, an innovator in the treatment of peripheral arterial disease (PAD), announced today that it has closed a $4M Series A funding round led by the Horowitz Group, a multi-asset class family investment office based in Newport Be... |
Show more